Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology

Margaret von Mehren, R. Lor Randall, Robert S. Benjamin, Sarah Boles, Marilyn M. Bui, Ernest U. Conrad, Kristen N. Ganjoo, Suzanne George, Ricardo J. Gonzalez, Martin J. Heslin, John M. Kane, Henry Koon, Joel Mayerson, Martin McCarter, Sean V. McGarry, Christian Meyer, Richard J. O'Donnell, Alberto S. Pappo, I. Benjamin Paz, Ivy A Petersen & 9 others John D. Pfeifer, Richard F. Riedel, Scott Schuetze, Karen D. Schupak, Herbert S. Schwartz, William D. Tap, Jeffrey D. Wayne, Mary Anne Bergman, Jillian Scavone

Research output: Contribution to journalArticle

118 Citations (Scopus)

Abstract

Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for Soft Tissue Sarcoma (available at NCCN.org) provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intra-abdominal/retroperitoneal STS, gastrointestinal stromal tumor, desmoid tumors, and rhabdomyosarcoma. This manuscript discusses guiding principles for the diagnosis and staging of STS and evidence for treatment modalities that include surgery, radiation, chemoradiation, chemotherapy, and targeted therapy.

Original languageEnglish (US)
Pages (from-to)758-786
Number of pages29
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume14
Issue number6
StatePublished - Jun 1 2016

Fingerprint

Practice Guidelines
Sarcoma
Aggressive Fibromatosis
Neoplasms
Gastrointestinal Stromal Tumors
Rhabdomyosarcoma
Therapeutics
Connective Tissue
Blood Vessels
Neck
Extremities
Fats
Head
Guidelines
Radiation
Drug Therapy
Muscles

ASJC Scopus subject areas

  • Oncology

Cite this

von Mehren, M., Randall, R. L., Benjamin, R. S., Boles, S., Bui, M. M., Conrad, E. U., ... Scavone, J. (2016). Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 14(6), 758-786.

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. / von Mehren, Margaret; Randall, R. Lor; Benjamin, Robert S.; Boles, Sarah; Bui, Marilyn M.; Conrad, Ernest U.; Ganjoo, Kristen N.; George, Suzanne; Gonzalez, Ricardo J.; Heslin, Martin J.; Kane, John M.; Koon, Henry; Mayerson, Joel; McCarter, Martin; McGarry, Sean V.; Meyer, Christian; O'Donnell, Richard J.; Pappo, Alberto S.; Paz, I. Benjamin; Petersen, Ivy A; Pfeifer, John D.; Riedel, Richard F.; Schuetze, Scott; Schupak, Karen D.; Schwartz, Herbert S.; Tap, William D.; Wayne, Jeffrey D.; Bergman, Mary Anne; Scavone, Jillian.

In: Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 14, No. 6, 01.06.2016, p. 758-786.

Research output: Contribution to journalArticle

von Mehren, M, Randall, RL, Benjamin, RS, Boles, S, Bui, MM, Conrad, EU, Ganjoo, KN, George, S, Gonzalez, RJ, Heslin, MJ, Kane, JM, Koon, H, Mayerson, J, McCarter, M, McGarry, SV, Meyer, C, O'Donnell, RJ, Pappo, AS, Paz, IB, Petersen, IA, Pfeifer, JD, Riedel, RF, Schuetze, S, Schupak, KD, Schwartz, HS, Tap, WD, Wayne, JD, Bergman, MA & Scavone, J 2016, 'Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 14, no. 6, pp. 758-786.
von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Conrad EU et al. Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2016 Jun 1;14(6):758-786.
von Mehren, Margaret ; Randall, R. Lor ; Benjamin, Robert S. ; Boles, Sarah ; Bui, Marilyn M. ; Conrad, Ernest U. ; Ganjoo, Kristen N. ; George, Suzanne ; Gonzalez, Ricardo J. ; Heslin, Martin J. ; Kane, John M. ; Koon, Henry ; Mayerson, Joel ; McCarter, Martin ; McGarry, Sean V. ; Meyer, Christian ; O'Donnell, Richard J. ; Pappo, Alberto S. ; Paz, I. Benjamin ; Petersen, Ivy A ; Pfeifer, John D. ; Riedel, Richard F. ; Schuetze, Scott ; Schupak, Karen D. ; Schwartz, Herbert S. ; Tap, William D. ; Wayne, Jeffrey D. ; Bergman, Mary Anne ; Scavone, Jillian. / Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. In: Journal of the National Comprehensive Cancer Network : JNCCN. 2016 ; Vol. 14, No. 6. pp. 758-786.
@article{3b7085b7dfa54949be7d3e3ab806a79a,
title = "Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology",
abstract = "Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for Soft Tissue Sarcoma (available at NCCN.org) provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intra-abdominal/retroperitoneal STS, gastrointestinal stromal tumor, desmoid tumors, and rhabdomyosarcoma. This manuscript discusses guiding principles for the diagnosis and staging of STS and evidence for treatment modalities that include surgery, radiation, chemoradiation, chemotherapy, and targeted therapy.",
author = "{von Mehren}, Margaret and Randall, {R. Lor} and Benjamin, {Robert S.} and Sarah Boles and Bui, {Marilyn M.} and Conrad, {Ernest U.} and Ganjoo, {Kristen N.} and Suzanne George and Gonzalez, {Ricardo J.} and Heslin, {Martin J.} and Kane, {John M.} and Henry Koon and Joel Mayerson and Martin McCarter and McGarry, {Sean V.} and Christian Meyer and O'Donnell, {Richard J.} and Pappo, {Alberto S.} and Paz, {I. Benjamin} and Petersen, {Ivy A} and Pfeifer, {John D.} and Riedel, {Richard F.} and Scott Schuetze and Schupak, {Karen D.} and Schwartz, {Herbert S.} and Tap, {William D.} and Wayne, {Jeffrey D.} and Bergman, {Mary Anne} and Jillian Scavone",
year = "2016",
month = "6",
day = "1",
language = "English (US)",
volume = "14",
pages = "758--786",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "6",

}

TY - JOUR

T1 - Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology

AU - von Mehren, Margaret

AU - Randall, R. Lor

AU - Benjamin, Robert S.

AU - Boles, Sarah

AU - Bui, Marilyn M.

AU - Conrad, Ernest U.

AU - Ganjoo, Kristen N.

AU - George, Suzanne

AU - Gonzalez, Ricardo J.

AU - Heslin, Martin J.

AU - Kane, John M.

AU - Koon, Henry

AU - Mayerson, Joel

AU - McCarter, Martin

AU - McGarry, Sean V.

AU - Meyer, Christian

AU - O'Donnell, Richard J.

AU - Pappo, Alberto S.

AU - Paz, I. Benjamin

AU - Petersen, Ivy A

AU - Pfeifer, John D.

AU - Riedel, Richard F.

AU - Schuetze, Scott

AU - Schupak, Karen D.

AU - Schwartz, Herbert S.

AU - Tap, William D.

AU - Wayne, Jeffrey D.

AU - Bergman, Mary Anne

AU - Scavone, Jillian

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for Soft Tissue Sarcoma (available at NCCN.org) provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intra-abdominal/retroperitoneal STS, gastrointestinal stromal tumor, desmoid tumors, and rhabdomyosarcoma. This manuscript discusses guiding principles for the diagnosis and staging of STS and evidence for treatment modalities that include surgery, radiation, chemoradiation, chemotherapy, and targeted therapy.

AB - Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for Soft Tissue Sarcoma (available at NCCN.org) provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intra-abdominal/retroperitoneal STS, gastrointestinal stromal tumor, desmoid tumors, and rhabdomyosarcoma. This manuscript discusses guiding principles for the diagnosis and staging of STS and evidence for treatment modalities that include surgery, radiation, chemoradiation, chemotherapy, and targeted therapy.

UR - http://www.scopus.com/inward/record.url?scp=85010208871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010208871&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 758

EP - 786

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 6

ER -